Systemic Inflammation, Atrial Fibrillation, and Cancer
2002; Lippincott Williams & Wilkins; Volume: 106; Issue: 9 Linguagem: Inglês
10.1161/01.cir.0000028399.42411.13
ISSN1524-4539
AutoresStefano Guzzetti, Giorgio Costantino, Camilla Fundarò,
Tópico(s)Drug-Induced Adverse Reactions
ResumoHomeCirculationVol. 106, No. 9Systemic Inflammation, Atrial Fibrillation, and Cancer Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBSystemic Inflammation, Atrial Fibrillation, and Cancer Stefano Guzzetti, Giorgio Costantino and Camilla Fundarò Stefano GuzzettiStefano Guzzetti Ospedale Luigi Sacco, Milano, Italy Search for more papers by this author , Giorgio CostantinoGiorgio Costantino Ospedale Luigi Sacco, Milano, Italy Search for more papers by this author and Camilla FundaròCamilla Fundarò Ospedale Luigi Sacco, Milano, Italy Search for more papers by this author Originally published27 Aug 2002https://doi.org/10.1161/01.CIR.0000028399.42411.13Circulation. 2002;106:e40To the Editor:The article by Chung et al1 reports a significant elevation of C-reactive protein (CRP) in patients with atrial fibrillation (AF). The CRP elevation was found both in patients with lone arrhythmia and in patients with structural heart disease. Moreover, the higher CRP levels were seen in patients with persistent, rather than paroxysmal, AF.We recently conducted a study to quantify the clinical observation of an unexpectedly high frequency of AF in patients with colorectal cancer.2 We considered a total of 1463 patients admitted to our Department of Surgery from 1987 to 1998 for surgical treatment of colorectal cancer (case group; mean age 66.0 years, 54% males) or nonneoplastic diseases including inguinal hernia, cholelithiasis, varicose veins, and hemorrhoids (control group; mean age 65.6 years, 61% males). We found that atrial fibrillation was three times as likely in patients with first diagnosis of colorectal cancer compared with controls (Mantel-Haenszel sex-adjusted odds ratio=3.5; Cornfield 95% confidence interval=1.6 to 7.2). Logistic analysis was used to exclude an effect of age. All of the patients studied were at the first stage of their diagnosis of colorectal cancer, and they had not received any chemotherapy or previous major surgery.Different pathophysiological mechanisms could explain our observations: a clinical or subclinical hyperthyroidism related to an abnormal release of thyroid-stimulating hormone or T3-like peptides by the tumor; an imbalance between sympathetic and parasympathetic cardiac autonomic control; an autoimmune paraneoplastic syndrome with inflammatory involvement of atrial structures as antigens.3Chung et al1 suggest in their article that AF could be promoted and maintained by atrial structural remodeling because of an inflammatory state, and that elevated CPR may reflect this condition. The cause of the inflammatory state remains unknown.1 Taking into account the results of our study, the presence of a tumor can sustain systemic inflammation with CPR elevations and could predispose some patients to the development of AF. Moreover, the higher mortality reportedly associated with AF, even after adjustment for preexisting cardiovascular conditions, 4 could be explained in some of these patients by the presence of an inflammatory state due to an occult neoplasm or other systemic inflammatory diseases.1 Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias. Circulation. 2001; 104: 2886–2891.CrossrefMedlineGoogle Scholar2 Guzzetti S, Costantino G, Sada S, et al. Colorectal cancer and atrial fibrillation: a case-control study. Am J Med. 2002; 112: 587–588.CrossrefMedlineGoogle Scholar3 Maixent JM, Paganelli F, Scaglione J, et al. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophisiol. 1998; 9: 612–617.CrossrefMedlineGoogle Scholar4 Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation. 1998; 98: 946–952.CrossrefMedlineGoogle ScholarcirculationahaCirculationCirculationCirculation0009-73221524-4539Lippincott Williams & WilkinsResponseChung Mina K., , Martin David O., , Sprecher Dennis, , Wazni Oussama, , Kanderian Anne, , Tchou Patrick J., , Niebauer Mark J., , Natale Andrea, , Van Wagoner David R., , Carnes Cynthia A., , and Bauer John A., 27082002The letter of Dr Guzzetti and colleagues reports that the incidence of atrial fibrillation is higher in patients with colorectal cancer. Neoplastic diseases could certainly provide the basis for an inflammatory state that could promote atrial fibrillation. Their study thus offers corroborative evidence linking atrial fibrillation and inflammation. In our study,1 a history of cancer was reported in 28/202 patients. Cancer was significantly associated with atrial arrhythmias (4/71 [5.6%] of patients without and 24/131 [18.3%] of patients with atrial arrhythmias had history of cancer, P=0.018). Cancer was also significantly associated with elevation of C-reactive protein (CRP) levels (0.36±0.06 mg/dL without and 0.51±0.10 mg/dL with history of cancer, nonparametric test P=0.005) in univariate analysis. However, multivariate analysis did not identify cancer as an independent predictor of atrial arrhythmias. The finding that cancer was not an independent predictor of atrial arrhythmias after adjusting for CRP levels is consistent with inflammation being the causal intermediary link between cancer and atrial fibrillation. eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Gonçalves-Teixeira P, Costa T, Fragoso I, Ferreira D, Brandão M, Leite-Moreira A, Sampaio F, Ribeiro J and Fontes-Carvalho R (2022)(2022)(2022)(2022) Rastreamento, Diagnóstico e Manejo da Fibrilação Atrial em Pacientes com Câncer: Evidências Atuais e Perspectivas Futuras, Arquivos Brasileiros de Cardiologia, 10.36660/abc.20201362, 119:2, (328-341), Online publication date: 29-Jul-2022., Online publication date: 29-Jul-2022., ., . Murtaza M, Baig M, Ahmed J, Serbanoiu L and Busnatu S (2022) Higher Mortality Associated With New-Onset Atrial Fibrillation in Cancer Patients: A Systematic Review and Meta-Analysis, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.867002, 9 Ostroumova O, Chernyaeva M, Kochetkov A, Vorobieva A, Bakhteeva D, Korchagina S, Bondarets O, Boyko N and Sychev D (2022) Drug-Induced Atrial Fibrillation / Atrial Flutter, Rational Pharmacotherapy in Cardiology, 10.20996/1819-6446-2021-12-11, 17:6, (1-18) Vasyuk Y, Shupenina E, Vyzhigin D, Novosel E and Gallinger K (2022) Atrial Fibrillation in Cancer Patients: Who is at Risk?, Rational Pharmacotherapy in Cardiology, 10.20996/1819-6446-2021-12-03, 17:6, (900-907) Eitel C, Sciacca V, Bartels N, Saraei R, Fink T, Keelani A, Gaßmann A, Kuck K, Vogler J, Heeger C and Tilz R (2021) Safety and Efficacy of Cryoballoon Based Pulmonary Vein Isolation in Patients with Atrial Fibrillation and a History of Cancer, Journal of Clinical Medicine, 10.3390/jcm10163669, 10:16, (3669) Lee C, Maan A, Singh J and Fradley M (2021) Arrhythmias and device therapies in patients with cancer therapy-induced cardiomyopathy, Heart Rhythm, 10.1016/j.hrthm.2021.02.017, 18:7, (1223-1229), Online publication date: 1-Jul-2021. Ostroumova O, Chernyaeva M, Kochetkov A, Bakhteeva D, Ivanov S and Sychev D (2020) Atrial Fibrillation Associated with Anticancer Drugs, Safety and Risk of Pharmacotherapy, 10.30895/2312-7821-2020-8-4-178-190, 8:4, (178-190) Strous M, Daniels A, Zimmermann F, van Erning F, Gidron Y, Vogelaar F and Emilsson L (2020) Is pre-operative heart rate variability a prognostic indicator for overall survival and cancer recurrence in patients with primary colorectal cancer?, PLOS ONE, 10.1371/journal.pone.0237244, 15:8, (e0237244) Higuchi S, Kabeya Y, Matsushita K, Arai N, Tachibana K, Tanaka R, Kawachi R, Takei H, Suzuki Y, Kogure M, Imanishi Y, Moriyama K, Sugiyama M, Yorozu T, Saito K, Abe N, Kondo H and Yoshino H (2019) Perioperative Atrial Fibrillation in Noncardiac Surgeries for Malignancies and One-Year Recurrence, Canadian Journal of Cardiology, 10.1016/j.cjca.2019.07.008, 35:11, (1449-1456), Online publication date: 1-Nov-2019. Yuan M, Zhang Z, Tse G, Feng X, Korantzopoulos P, Letsas K, Yan B, Wu W, Zhang H, Li G, Liu T and Xia Y (2019) Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis, Cardiology Research and Practice, 10.1155/2019/8985273, 2019, (1-9), Online publication date: 14-Apr-2019. Yang X, Li X, Yuan M, Tian C, Yang Y, Wang X, Zhang X, Sun Y, He T, Han S, Chen G, Liu N, Gao Y, Hu D, Xing Y and Shang H (2018) Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms, Frontiers in Pharmacology, 10.3389/fphar.2018.01058, 9 Hung C, Chang C, Lin J, Ho Y, Chen M and Novo G (2018) The association between new onset atrial fibrillation and incident cancer—A nationwide cohort study, PLOS ONE, 10.1371/journal.pone.0199901, 13:6, (e0199901) Elbadawi A, Elgendy I, Ha L, Baig B, Saad M, Adly H, Ogunbayo G, Olorunfemi O, Mckillop M and Maffett S (2018) In-Hospital Cerebrovascular Outcomes of Patients With Atrial Fibrillation and Cancer (from the National Inpatient Sample Database), The American Journal of Cardiology, 10.1016/j.amjcard.2017.11.027, 121:5, (590-595), Online publication date: 1-Mar-2018. Chang H, Okwuosa T, Scarabelli T, Moudgil R and Yeh E (2017) Cardiovascular Complications of Cancer Therapy, Journal of the American College of Cardiology, 10.1016/j.jacc.2017.09.1095, 70:20, (2552-2565), Online publication date: 1-Nov-2017. Mery B, Guichard J, Guy J, Vallard A, Barthelemy J, Da Costa A, Magné N and Bertoletti L (2017) Atrial fibrillation in cancer patients: Hindsight, insight and foresight, International Journal of Cardiology, 10.1016/j.ijcard.2017.03.132, 240, (196-202), Online publication date: 1-Aug-2017. Wassertheil-Smoller S, McGinn A, Martin L, Rodriguez B, Stefanick M and Perez M (2017) The Associations of Atrial Fibrillation With the Risks of Incident Invasive Breast and Colorectal Cancer, American Journal of Epidemiology, 10.1093/aje/kww185, 185:5, (372-384), Online publication date: 1-Mar-2017. Maurea N, Parrini I and Lestuzzi C (2017) Arrhythmias and Electrolyte Imbalances as Consequences of Cancer Manual of Cardio-oncology, 10.1007/978-3-319-40236-9_5, (75-88), . Dumas G and Canet E (2016) Effets cardiovasculaires graves des chimiothérapies, thérapies ciblées et des traitements immunosuppresseursCardiovascular toxicity due to chemotherapy, targeted therapies, and immunosuppressive drugs: a narrative review, Réanimation, 10.1007/s13546-015-1161-4, 25:S3, (123-136), Online publication date: 1-Jul-2016. Nouraie M, Kansal V, Belfonte C, Ghazvini M, Haidari T, Shahnazi A, Brim H, Soliman E, Ashktorab H and Gallyas F (2015) Atrial Fibrillation and Colonic Neoplasia in African Americans, PLOS ONE, 10.1371/journal.pone.0135609, 10:8, (e0135609) Farmakis D, Parissis J and Filippatos G (2014) Insights Into Onco-Cardiology, Journal of the American College of Cardiology, 10.1016/j.jacc.2013.11.026, 63:10, (945-953), Online publication date: 1-Mar-2014. Berardi R, Caramanti M, Savini A, Chiorrini S, Pierantoni C, Onofri A, Ballatore Z, De Lisa M, Mazzanti P and Cascinu S (2013) State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review, Critical Reviews in Oncology/Hematology, 10.1016/j.critrevonc.2013.02.007, 88:1, (75-86), Online publication date: 1-Oct-2013. Erichsen R, Christiansen C, Mehnert F, Weiss N, Baron J and Sørensen H (2011) Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case–control study, Internal and Emergency Medicine, 10.1007/s11739-011-0701-9, 7:5, (431-438), Online publication date: 1-Oct-2012. Tamargo J, Caballero R and Delpón E (2012) Drug-induced atrial fibrillation, Expert Opinion on Drug Safety, 10.1517/14740338.2012.698609, 11:4, (615-634), Online publication date: 1-Jul-2012. (2011) 重症心不全症例に対する心臓再同期療法と僧帽弁形成術の併用治療の可能性(3.心臓再同期療法の適応と課題, 第74回日本循環器学会学術集会), Journal of JCS Cardiologists, 10.1253/jjcsc.19.1_61, 19:1, (61-65), Online publication date: 25-Apr-2011. Arslan C, Aksoy S, Dizdar O, S. Dede D, Harputluoglu H and Altundag K (2010) Zoledronic acid and atrial fibrillation in cancer patients, Supportive Care in Cancer, 10.1007/s00520-010-0868-z, 19:3, (425-430), Online publication date: 1-Mar-2011. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S and Noonan D (2010) Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention, JNCI: Journal of the National Cancer Institute, 10.1093/jnci/djp440, 102:1, (14-25), Online publication date: 6-Jan-2010. Lainscak M, Dagres N, Filippatos G, Anker S and Kremastinos D (2008) Atrial fibrillation in chronic non-cardiac disease: Where do we stand?, International Journal of Cardiology, 10.1016/j.ijcard.2007.12.078, 128:3, (311-315), Online publication date: 1-Aug-2008. Skarvan K and Bernet F (2005) Ischämische MitralklappeninsuffizienzIschemic mitral regurgitation, Intensivmedizin und Notfallmedizin, 10.1007/s00390-005-0646-1, 42:7, (603-613), Online publication date: 1-Oct-2005. Tibayan F, Rodriguez F, Langer F, Liang D, Daughters G, Ingels N and Miller D (2004) Undersized Mitral Annuloplasty Alters Left Ventricular Shape During Acute Ischemic Mitral Regurgitation, Circulation, 110:11_suppl_1, (II-98-II-102), Online publication date: 14-Sep-2004.Tibayan F, Rodriguez F, Zasio M, Bailey L, Liang D, Daughters G, Langer F, Ingels N and Miller D (2003) Geometric Distortions of the Mitral Valvular-Ventricular Complex in Chronic Ischemic Mitral Regurgitation, Circulation, 108:10_suppl_1, (II-116-II-121), Online publication date: 9-Sep-2003. August 27, 2002Vol 106, Issue 9 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000028399.42411.13PMID: 12196350 Originally publishedAugust 27, 2002 PDF download Advertisement
Referência(s)